# A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

> **NCT07594769** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** ODT2 Test formulation
- **DRUG:** ODT Reference formulation

## Key facts

- **NCT ID:** NCT07594769
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-05-11
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07594769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07594769, "A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07594769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
